Paroxysmal nocturnal hemoglobinuria is a rare acquired blood disorder that affects red blood cells, white blood cells, and platelets. It develops when a genetic change occurs in a blood forming stem cell, causing certain blood cells to become vulnerable to destruction by the complement system. PNH is not usually inherited from parents, and its exact cause is not fully understood.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder involving the bone marrow and blood cells. It occurs when a mutation develops in the PIGA gene within a blood-forming stem cell. This mutation can cause blood cells produced from that stem cell to lack certain protective proteins, making them more vulnerable to destruction by the complement system. PNH is an acquired condition, meaning the responsible mutation generally develops during a person's lifetime rather than being passed down through families.
The precise reason why some people develop the PIGA mutation is not completely understood. PNH can occur in people without an obvious underlying condition, but it is also associated with certain disorders affecting bone marrow function.
Some important factors and associations include:
Acquired PIGA mutations: A mutation in a blood-forming stem cell is central to the development of PNH.
Bone marrow disorders: PNH may occur alongside conditions such as aplastic anemia and myelodysplastic syndromes.
Aplastic anemia: People with aplastic anemia may have small populations of PNH cells, and these clones can sometimes become more prominent over time.
Abnormal blood cell production: Disorders that affect the bone marrow may create circumstances in which PNH stem cell clones gain an advantage.
Immune system activity: Changes in immune activity within the bone marrow may influence the survival and expansion of PNH cell populations.
Age: PNH can occur at different ages, although it is commonly diagnosed in adults.
Having one of these conditions does not mean that a person will definitely develop clinically significant PNH. PNH can also develop without a clearly identifiable risk factor.
PNH risk factors are different from risk factors for many common diseases because the disorder results from an acquired genetic change rather than a straightforward inherited tendency. Doctors may consider PNH when someone has unexplained hemolysis, low blood cell counts, blood clots in unusual locations, or other findings that suggest abnormal destruction of blood cells.
Evaluation may involve several blood tests and specialized testing to identify PNH cell populations. Flow cytometry is commonly used to detect blood cells that lack specific proteins associated with PNH. Doctors may also investigate possible underlying bone marrow conditions when blood counts or other findings are abnormal.
Important considerations include:
Unexplained anemia: Persistent anemia, particularly when accompanied by evidence of red blood cell destruction, may require further investigation.
Hemolysis: Increased breakdown of red blood cells can be an important clinical clue.
Low blood cell counts: Reduced red cells, white cells, or platelets may occur when bone marrow function is affected.
Unusual blood clots: PNH is associated with an increased risk of thrombosis, including clots occurring in less typical locations.
Bone marrow evaluation: Additional testing may be considered when aplastic anemia or another marrow disorder is suspected.
Specialized testing: Flow cytometry can help identify and measure abnormal PNH cell populations.
Paroxysmal nocturnal hemoglobinuria is an uncommon acquired blood disorder caused by a genetic change in a blood-forming stem cell. Its exact cause is not fully established, and there is no single lifestyle factor known to cause PNH. Associations with bone marrow disorders such as aplastic anemia are important because PNH clones can occur in these settings. Recognizing possible clinical associations can support timely evaluation when unexplained anemia, hemolysis, low blood counts, or unusual blood clots occur. Medical professionals can determine whether specialized testing is appropriate based on an individual's symptoms, medical history, and laboratory findings.